Breaking News

Catalent, Exelixis Extend Cometriq Partnership

December 7, 2012

Will serve as exclusive commercial supplier for U.S. market

Catalent has entered into an agreement with Exelixis to supply CometriqT (Cabozantinib) for the U.S. market. CometriqT has been approved by the FDA for the treatment of progressive, metastatic medullary thyroid cancer (MTC).
Under an existing five-year partnership, Catalent has provided analytical, clinical trial supply and manufacturing support for Cometriq and will continue to be the exclusive commercial drug supply partner for the 20 mg and 80 mg capsule dose packs in the U.S. All capsule manufacturing and packaging operations will take place at Catalent’s 450,000-sq.-ft. facility in Kansas City, MO.
“Catalent supports pharmaceutical companies, small and large, to help them accelerate their drug development and bring new treatments to improve patient’s lives,” said Scott Houlton, president of Development and Clinical Services at Catalent. “We have worked closely with Exelixis over the past several years on COMETRIQ and are delighted to have reached this key milestone.”
“We have been pleased to partner with Catalent for the past five years. Catalent has provided high quality service for analytical testing, manufacturing process development and validation.  This partnership has truly helped advance this important product for cancer patients,” said JoAnn Wilson, vice president, Chemical, Manufacturing and Control at Exelixis, Inc.

Related Packaging:

Related Contract Manufacturing:

Related Compliance:

blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.